Nuveen, LLC Agios Pharmaceuticals, Inc. Transaction History
Nuveen, LLC
- $315 Billion
- Q1 2025
A detailed history of Nuveen, LLC transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Nuveen, LLC holds 83,409 shares of AGIO stock, worth $2.5 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
83,409Holding current value
$2.5 Million% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AGIO
# of Institutions
244Shares Held
58.7MCall Options Held
300KPut Options Held
362K-
Farallon Capital Management LLC San Francisco, CA5.67MShares$170 Million0.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.6MShares$168 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$146 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.52MShares$105 Million2.3% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.42MShares$72.6 Million0.01% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $1.64B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...